This inventor holds 1 USPTO granted patent. Top assignees: Ionis Pharmaceuticals, Inc., University of California. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 289 
1 out of 16,048 
Years Active: 2019
Title: Brian Parks: Innovator in Cardiometabolic Disease Research
Introduction
Brian Parks is a notable inventor based in Los Angeles, CA. He has made significant contributions to the field of cardiometabolic disease research. His innovative work focuses on methods and compounds that can reduce the expression of AGPAT5 mRNA and protein in animals.
Latest Patents
Brian Parks holds a patent for the modulation of AGPAT5 expression. This patent outlines methods, compounds, and compositions aimed at reducing lipids, insulin resistance, and glucose levels in animals. These advancements are particularly useful for treating, preventing, delaying, or ameliorating cardiometabolic diseases and related physiological markers in individuals in need.
Career Highlights
Throughout his career, Brian has worked with prestigious institutions, including the University of California and Ionis Pharmaceuticals, Inc. His experience in these organizations has allowed him to develop and refine his innovative approaches to health and disease management.
Collaborations
Brian has collaborated with notable professionals in his field, including Aldons J Lusis. These partnerships have further enhanced his research and contributions to cardiometabolic health.
Conclusion
Brian Parks is a dedicated inventor whose work in cardiometabolic disease research has the potential to make a significant impact on health outcomes. His innovative methods and compounds are paving the way for new treatments and improved patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile